Insmed Inc. buy JPMorgan Chase & Co.
Start price
10.08.26
/
50%
€116.82
Target price
10.08.27
€151.46
Performance (%)
-1.69%
Price
12.08.26
?
Summary
This prediction is currently active. With a performance of -1.69%, the BUY prediction for Insmed Inc. by JPMorgan_Chase___Co_ is down slightly. This prediction currently runs until 10.08.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Insmed Inc. | -1.69% |
| iShares Core DAX® | 0.184% |
| iShares Nasdaq 100 | -0.770% |
| iShares Nikkei 225® | 0.733% |
| iShares S&P 500 | -0.166% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed (INSM) had its price target lowered by JPMorgan Chase & Co. from $179.00 to $175.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat